The purpose of this study was to determine in a randomized, prospective manner whether administration of total parenteral nutrition (TPN) via multilumen catheters increases the risk of catheterrelated sepsis (CRS). All patients receiving hyperalimentation during a 24-month period were randomized to receive either a double-lumen catheter (DLC) or a triple-lumen catheter (TLC). A total of 101 catheters were placed in 79 patients, of which 49 were DLCs and 52 were TLCs. The patients with DLCs received a total of 784 days of TPN, whereas patients with TLCs received a total of 754 days of TPN. CRS was associated with one (2.0%) of the 49 DLCs vs. one (1.9%) of the 52 TLCs. In comparison, the rate of CRS associated with single-lumen catheters (historical control) at our institution was 1.4% (P ú .90). We conclude that the use of multilumen catheters in TPN therapy does not result in an increased risk of CRS.
Total parenteral nutrition (TPN) is required in many hospitalnity to participate in this open, randomized, prospective trial.
Patients were randomized to receive catheters according to their ized patients who cannot meet their nutritional needs enterally. An important potential complication related to TPN administrasocial security numbers -those with an even number received tion is catheter-related sepsis (CRS) [1] . Some studies have a double-lumen catheter (DLC) , while those with an odd numsuggested that the risk of CRS is increased by the use of tripleber received a TLC. Informed consent was obtained from each lumen catheters (TLCs) [2 -4] . Previous studies have shown patient in accordance with Veterans Administration guidelines. that administration of TPN through TLCs is associated with a
The study was approved by the Department of Veterans Affairs higher risk of CRS than is administration through single-lumen (Long Beach) Human Studies Committee and Research and catheters (SLCs) [2 -4] . The rate of CRS related to TLCs has Development Committee. been reported to be as high as 10% -25%, compared with a Both DLCs and TLCs were polyurethane 7F catheters rate of 0 -6% associated with SLCs [2 -4] . Thus, the use of (Arrow International, Reading, PA) that were made to be in-TLC in TPN therapy has been deemed unsafe by some investiserted over a guide wire by means of the Seldinger technique. gators. Because many of the patients who require TPN therapy All catheters were inserted by surgical or medical house staff are critically ill and have poor venous access, the use of TLCs by using a sterile technique and were sutured to the skin. Strict in these patients would allow additional access ports for admincompliance with the sterile technique was ensured by having istration of compatible medications and intravenous solutions the nutritional support team (NST) nurse present at all proceand eliminate the need for additional intravenous catheters.
dures. The catheter was inserted into the internal jugular or the The purpose of this randomized, prospective study was to subclavian vein, depending on the preference of the individual determine whether multilumen catheters increase the risk of inserting the catheter. Catheter insertion occurred at either an CRS when used for administration of TPN. In addition, the intensive care unit bed or medical/surgical ward bed at our rate of CRS related to TPN administration at the Long Beach institution. Veterans Affairs Medical Center (LBVAMC; Long Beach, CA)
A chest radiograph was obtained after the insertion of each for the past 15 years was reviewed. Our data suggest that catheter to ensure that no complications occurred during cathemultilumen catheters are safe for administering TPN and do ter insertion. Povidine-iodine ointment was placed at the insernot increase the risk of CRS. tion and suture sites, which were covered with occlusive dressings. Dressings were changed three times a week by the NST Methods nurse, with staff nurses changing the dressings as needed if All patients who required central hyperalimentation from they became loose or soiled. All solutions were infused via June 1994 to June 1996 at LBVAMC were offered the opportuinfusion pumps. Intravenous tubing and connectors were changed every 48 hours, and no filters were used. All patients were monitored by the NST nurse 5 days a week for overall CRS was defined as previously described by other investigators [1] . Specifically, criteria for CRS were as follows: an episode of fever, leukocytosis, and a positive catheter tip culResults ture with no other infection present that resolved with the During the 2-year study period, 80 patients were identified removal of the catheter, or a positive blood culture and a cathefor the study. All of these patients agreed to participate in the ter tip culture that was positive for the same organism with no study. One patient was excluded from the study because of an other source of infection identified. Two patients developed underlying coagulopathy, which necessitated placement of his CRS during the study (table 3 ). Using the criteria described catheter into a femoral vein. One hundred one catheters were above, CRS occurred in one patient who had a DLC inserted placed in 79 patients who required TPN (table 1) . There were into the internal jugular vein (2.0%; 1.28 infections per 1,000 49 DLCs and 52 TLCs. The patient profiles and principal diagdays of catheterization) and one patient who had a TLC inserted noses are shown in tables 1 and 2, respectively.
into the subclavian vein (1.9%; 1.33 infections per 1,000 days There was no statistically significant difference (P £ .05) of catheterization). The patient with the DLC was infected with in the patient profile (age, sex, number of patients, or number Staphylococcus epidermidis (13th day), and the patient with of patients in an intensive care unit) or the principal diagnosis the TLC was infected with Candida parapsilosis (21st day). between the two groups. It should be noted that more patients Bacteremia also occurred in two patients with DLCs and two with DLCs had catheters inserted through the internal jugular with TLCs during the course of the study, but another source vein than did patients with TLCs, but the difference did not was identified as the cause of the infection. reach statistical significance (P Å .06). TPN was administered There was no significant difference in the rates of CRS through DLCs for a total of 784 days, while TPN was adminisbetween patients with DLCs and those with TLCs (P Å .97). tered through TLCs for a total of 754 days. There were no
The duration of the indwelling catheters ranged from 2 to 65 days (figure 1). The average duration was 14.5 days for TLCs vs. 16 days for DLCs. x 2 analysis of CRS between each of NOTE. DLC Å double-lumen catheter; TLC Å triple-lumen catheter; TPN NOTE. DLC Å double-lumen catheter; ICU Å intensive care unit; TLC Å triple-lumen catheter; TPN Å total parenteral nutrition.
Å total parenteral nutrition.
with SLCs (1.4%) [6] . It should be noted that rates of CRS related to TPN therapy at LBVAMC before 1982 were alarmingly high, ranging between 15% and 30% per year; before 1982, only SLCs were used for TPN therapy. Because of the unacceptably high rates of CRS, an NST was formed in 1982 in an attempt to reduce the high rate of catheter-related infection. The NST is a multidisciplinary team consisting of a general surgeon, a gastroenterologist, a nephrologist, an infectious diseases specialist, a pharmacist, an NST nurse, an infectious diseases nurse, and a dietitian. The NST nurse was a dedicated member of the NST and monitored all TPN catheters on a daily basis. Since the inception of the NST, rates of catheterrelated infections have decreased dramatically and have remained low (Ç1% -2% per year). Our study addresses several important issues concerning the risk of infection related to the use of central venous catheters for TPN administration. First, our data showing low rates of Pemberton et al. [4] , McCarthy et al. [3] , and Yeung et al. [2] TPN through double-lumen catheters (DLCs). There were two cases demonstrated that the rates of CRS associated with TLCs were of catheter-related sepsis: one in a patient with a DLC between days higher than those associated with SLCs, prompting these inves-11 and 15, and one in a patient with a TLC between days 21 and 25.
tigators to conclude that TLCs should not be used for TPN There were no significant differences in the rates of catheter-related therapy. In a more recent nonrandomized study, Savage et al.
sepsis between any of the groups of patients (P ú .64).
[10] reported a lower rate (4.4%) of CRS associated with 1,135 central venous catheters, of which 879 were TLCs. Although these investigators did not specifically state what the rate of durations (figure 1) revealed no significant differences in rates CRS associated with the 879 TLCs was, they suggested that of CRS between any of the groups (P ú .64). The rates of TLCs may be safe for TPN administration. CRS associated with DLCs and TLCs were also compared with
Other studies have reported various rates of CRS ranging the rates of CRS associated with DLCs between 1988 and 1994 between 1.3% and 27% [7, 11 -15] . Because of the wide differat LBVAMC (1.8%) and the historical infection rate [6] at ence in the experimental design of these studies, direct compari-LBVAMC associated with SLCs for TPN administration sons of the results are not possible. In the present study, the (1.4%). On the basis of the results of the x 2 analysis, there use of a TLC was limited to administration of compatible were no significant differences between the rates of CRS among medications and intravenous solutions. The administration of any of these groups (P ú .90).
blood products, withdrawal of blood, and measurements of central venous pressure were prohibited as these manipulations may increase the risk of catheter-related infections [4, 15, 16 ].
Discussion
Our data also suggest that routine scheduled changes of catheters are not necessary to lower the risk of CRS. In the The use of multilumen catheters for TPN administration is highly desirable because it provides multipurpose access to past, there have been various recommendations concerning the frequency of catheter changes. Some researchers have advocentral circulation and eliminates the need for additional intravenous access. The major concern with the use of multilumen cated routine changes as often as every 3 -4 days to every 7 -10 days [7, 11, 17, 18] ; other investigators have reported that catheters for TPN administration is the presumed increase in the risk of CRS [4, 7] . Since many patients requiring TPN frequent changes were not necessary, and that changes may be done on an as-needed basis [1, 6, 10, 13, 19, 20] . In our study, therapy are malnourished, critically ill, and immunocompromised, significant numbers are not able to survive episodes of the average duration of indwelling catheters was higher (14.5 days for TLCs and 16 days for DLCs) than that in other studies; CRS [1, 8, 9] . CRS related to TPN therapy is associated with mortality rates of up to 10% -20% [8] . Thus, prevention of however, the rates of CRS were low. Finally, we believe that the low rates of CRS observed in CRS in this high-risk population is crucial.
The results of this study indicate that use of multilumen the present study and in our institution during the past 15 years are attributable in part to the involvement of the NST, which catheters in TPN administration does not increase the risk for CRS. The rates of CRS associated with both TLCs and DLCs sets strictly adhered to guidelines and monitors all activity related to TPN therapy. In support of the importance of strictly were low (£2%) and in line with our experience at LBVAMC
